Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | transglutaminase 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0 | 0.5 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.0072 | 0.3454 | 0.3454 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0079 | 0.4395 | 0.4395 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0079 | 0.4395 | 0.4395 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.0043 | 0 | 0.5 |
Mycobacterium ulcerans | transglutaminase family protein | 0.0043 | 0 | 0.5 |
Giardia lamblia | Transglutaminase/protease, putative | 0.0043 | 0 | 0.5 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0043 | 0 | 0.5 |
Echinococcus granulosus | glutamate receptor NMDA | 0.0072 | 0.3454 | 0.3454 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0 | 0.5 |
Brugia malayi | Thioredoxin family protein | 0.0043 | 0 | 0.5 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.0043 | 0 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0043 | 0 | 0.5 |
Mycobacterium tuberculosis | Long conserved protein | 0.0043 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0043 | 0 | 0.5 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0054 | 0.1329 | 0.1329 |
Giardia lamblia | Hypothetical protein | 0.0043 | 0 | 0.5 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0043 | 0 | 0.5 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0109 | 0.797 | 1 |
Onchocerca volvulus | 0.0043 | 0 | 0.5 | |
Mycobacterium tuberculosis | Conserved protein | 0.0043 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0043 | 0 | 0.5 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0126 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.